Cargando…

Ketoglutaric acid can reprogram the immunophenotype of triple-negative breast cancer after radiotherapy and improve the therapeutic effect of anti-PD-L1

BACKGROUND: Great progress has been made in applying immunotherapy to the clinical treatment of tumors. However, many patients with triple-negative breast cancer (TNBC) cannot benefit from immunotherapy due to the immune desert type of TNBC, which is unresponsive to immunotherapy. DMKG, a cell-perme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Hongpei, Liu, Jiahao, Huang, Jing, Li, Yanan, Xie, Qiongxuan, Dong, Yuqian, Mi, Ze, Ma, Xiaoqian, Rong, Pengfei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337087/ https://www.ncbi.nlm.nih.gov/pubmed/37438720 http://dx.doi.org/10.1186/s12967-023-04312-2

Ejemplares similares

PCMT1 is a potential target related to tumor progression and immune infiltration in liver cancer
por: Liu, Jiahao, et al.
Publicado: (2023)

Preoperative Body Composition Combined with Tumor Metabolism Analysis by PET/CT Is Associated with Disease-Free Survival in Patients with NSCLC
por: Tan, Hongpei, et al.
Publicado: (2022)

Salmonella-mediated blood‒brain barrier penetration, tumor homing and tumor microenvironment regulation for enhanced chemo/bacterial glioma therapy
por: Mi, Ze, et al.
Publicado: (2023)

Controversial role of ILC3s in intestinal diseases: A novelty perspective on immunotherapy
por: Zhang, Yunshu, et al.
Publicado: (2023)

Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancer
por: Hammerl, Dora, et al.
Publicado: (2021)

Metabolic Reprogramming in Triple-Negative Breast Cancer
por: Sun, Xiangyu, et al.
Publicado: (2020)

Metabolic reprogramming in triple-negative breast cancer
por: Wang, Zhanyu, et al.
Publicado: (2020)

Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype
por: Elsheikh, S E, et al.
Publicado: (2008)

Comprehensively analysis of immunophenotyping signature in triple-negative breast cancer patients based on machine learning
por: Tang, Lijuan, et al.
Publicado: (2023)

Glucose Metabolism Reprogramming of Primary Tumor and the Liver Is Associated With Disease-Free Survival in Patients With Early NSCLC
por: Tan, Hongpei, et al.
Publicado: (2021)

α-ketoglutarate promotes the specialization of primordial germ cell-like cells through regulating epigenetic reprogramming
por: Xing, Ming, et al.
Publicado: (2021)

Comprehensive genomic and immunophenotypic analysis of CD4 T cell infiltrating human triple-negative breast cancer
por: Zhang, He, et al.
Publicado: (2020)

Targeting Alpha‐Ketoglutarate Disruption Overcomes Immunoevasion and Improves PD‐1 Blockade Immunotherapy in Renal Cell Carcinoma
por: Li, Le, et al.
Publicado: (2023)

α-Ketoglutarate inhibits autophagy
por: Baracco, Elisa Elena, et al.
Publicado: (2019)

Supplementation with α-ketoglutarate improved the efficacy of anti-PD1 melanoma treatment through epigenetic modulation of PD-L1
por: Liu, Nian, et al.
Publicado: (2023)

Combination of OX40 Co-Stimulation, Radiotherapy, and PD-1 Inhibition in a Syngeneic Murine Triple-Negative Breast Cancer Model
por: Han, Min Guk, et al.
Publicado: (2022)

D-mannose facilitates immunotherapy and radiotherapy of triple-negative breast cancer via degradation of PD-L1
por: Zhang, Ruonan, et al.
Publicado: (2022)

Spatial immunophenotypes orchestrate prognosis in triple-negative breast cancer with Miller-Payne grade 4 following neoadjuvant chemotherapy
por: Ma, Jianli, et al.
Publicado: (2023)

Targeting glutamine metabolic reprogramming of SLC7A5 enhances the efficacy of anti-PD-1 in triple-negative breast cancer
por: Huang, Renhong, et al.
Publicado: (2023)

Alpha-Ketoglutarate: Physiological Functions and Applications
por: Wu, Nan, et al.
Publicado: (2016)

Alpha-ketoglutarate for adipose tissue rejuvenation
por: Tian, Qiyu, et al.
Publicado: (2020)

Key Players in Choline Metabolic Reprograming in Triple-Negative Breast Cancer
por: Iorio, Egidio, et al.
Publicado: (2016)

MUC1 facilitates metabolomic reprogramming in triple-negative breast cancer
por: Goode, Gennifer, et al.
Publicado: (2017)

Therapeutic Potential of Tumor Metabolic Reprogramming in Triple-Negative Breast Cancer
por: Munkácsy, Gyöngyi, et al.
Publicado: (2023)

Defects in Macrophage Reprogramming in Cancer Therapy: The Negative Impact of PD-L1/PD-1
por: Cai, Hao, et al.
Publicado: (2021)

Comprehensive Analysis of DNA Methylation and Transcriptome to Identify PD-1-Negative Prognostic Methylated Signature in Endometrial Carcinoma
por: Cao, Lu, et al.
Publicado: (2022)

AKT signaling is associated with epigenetic reprogramming via the upregulation of TET and its cofactor, alpha-ketoglutarate during iPSC generation
por: Sekita, Yoichi, et al.
Publicado: (2021)

Immunophenotype
por: Albani, Salvatore
Publicado: (2014)

Correction: MUC1 facilitates metabolomic reprogramming in triple-negative breast cancer
por: Goode, Gennifer, et al.
Publicado: (2017)

TGF-β induced reprogramming and drug resistance in triple-negative breast cells
por: Wu, Guoyu, et al.
Publicado: (2022)

The Antioxidative Function of Alpha-Ketoglutarate and Its Applications
por: Liu, Shaojuan, et al.
Publicado: (2018)

Heterogeneous cellular effects of α-ketoglutarate esters
por: Galluzzi, Lorenzo
Publicado: (2019)

The Regulatory Role of α-Ketoglutarate Metabolism in Macrophages
por: Liu, Shaojuan, et al.
Publicado: (2021)

Immune infiltration and immunophenotyping in atrial fibrillation
por: Tian, Yuqing, et al.
Publicado: (2023)

Immunophenotypic correlates of sustained MRD negativity in patients with multiple myeloma
por: Coffey, David G., et al.
Publicado: (2023)

The malate shuttle detoxifies ammonia in exhausted T cells by producing 2-ketoglutarate
por: Weisshaar, Nina, et al.
Publicado: (2023)

PD-1/PD-L1 Inhibitors Response in Triple-Negative Breast Cancer: Can Long Noncoding RNAs Be Associated?
por: Mathias, Carolina, et al.
Publicado: (2023)

PD-1 Independent Role of PD-L1 in Triple-Negative Breast Cancer Progression
por: Alkaabi, Duaa, et al.
Publicado: (2023)

Medium Chain Triglyceride (MCT) Oil Affects the Immunophenotype via Reprogramming of Mitochondrial Respiration in Murine Macrophages
por: Yu, Seungmin, et al.
Publicado: (2019)

Hexokinase 2 Is a Pivot for Lovastatin-induced Glycolysis-to-Autophagy Reprogramming in Triple-Negative Breast Cancer Cells
por: Xue, Lian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c08mudgjh6lpnolnquqkfdu6ac